UNSPSC 85892211: High dose rate (hdr) brachytherapy of salivary glands using iridium 192 (ir-192)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of salivary glands using iridium 192 (ir-192). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D91698Z

UNSPSC 85892211 High dose rate (HDR) brachytherapy of salivary glands using iridium 192 (IR-192) is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The single posted opportunity tagged under this code—Santa Clara County Health System's RFQ for temporary health professional staffing services—does not represent brachytherapy or any oncology-related procurement; instead, it solicits vendors across thirteen ancillary clinical categories including audiology, cardiology imaging, gastroenterology, orthopedics, respiratory care, sterile processing, and therapy services. The mismatch between the code's specific clinical designation and the actual work being solicited suggests either a tagging error by the issuing body or that this code does not reflect active state and local demand for specialized radiation oncology services at this time.

The Santa Clara County Health System RFQ, posted July 7, 2026 with a due date of October 7, 2026, establishes a non-exclusive qualified vendor pool with no guaranteed minimum work and explicit exclusion of nursing, physician, and other non-clinical staffing. Selected vendors are placed on a Qualified List maintained for up to five years, with contract terms and scope to be negotiated case-by-case as operational needs arise. All proposals must be submitted electronically, and offerors may propose for all or specific health professional categories without penalty. No other state or local opportunities under this code appear in the recent-solicitations dataset, and no information suggests regional or statewide concentration of demand for HDR brachytherapy services in the public procurement channel.